Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
Phase 4
Completed
- Conditions
- Bipolar Disorder
- Registration Number
- NCT00034580
- Lead Sponsor
- Eli Lilly and Company
- Brief Summary
This is a research study comparing the safety and efficacy of two active study medications for the treatment of bipolar I disorder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 326
Inclusion Criteria
- Male or female subject, 18-70 years of age
- Female subjects of childbearing potential must be using a medically accepted means of contraception
- Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol
- Subjects must be considered reliable
Exclusion:
- Female subjects who are either pregnant or nursing
- Uncorrected hypothyroidism or hyperthyroidism
- Narrow-angle glaucoma
- Subjects who present a serious and immediate risk of endangering him or herself
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method